CTSH or EPAM: Which Is the Better Value Stock Right Now?

Core Insights - Cognizant (CTSH) is currently rated 2 (Buy) by Zacks Rank, indicating a stronger earnings outlook compared to Epam (EPAM), which is rated 3 (Hold) [3] - CTSH has a Value grade of B, while EPAM has a Value grade of C, suggesting that CTSH is the superior value option at this time [6][7] Valuation Metrics - CTSH has a forward P/E ratio of 15.58, while EPAM has a forward P/E ratio of 16.42, indicating that CTSH may be undervalued relative to EPAM [5] - The PEG ratio for CTSH is 1.81, compared to EPAM's PEG ratio of 1.84, suggesting that CTSH offers better value when considering expected earnings growth [5] - CTSH's P/B ratio is 2.62, while EPAM's P/B ratio is 2.76, further supporting the notion that CTSH is a more attractive investment based on market value versus book value [6]